America & Europe Eye Drops Market Growth and Analysis by 2031

America & Europe Eye Drops Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Drug Class [Antibiotics (Moxifloxacin, Ciprofloxacin, Gentamycin, Chloramphenicol, and Others), Artificial Tears (Carboxymethylcellulose, Polyethylene Glycol, and Others), Steroids (Dexamethasone, Loteprednol, Fluocinolone, and Others), and Others], Application [Eye Diseases (Dry Eye, Cataract, Glaucoma, Refractive Error, and Others), Eye Care, and Others], Purchase Mode (Prescription and OTC), and Geography (America and Europe)

  • Status : Published
  • Report Code : TIPRE00039044
  • Category : Life Sciences
  • No. of Pages : 150
  • Available Report Formats : pdf-format excel-format

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the driving factors for the America & Europe eye drops market?

Key factors that are driving the America & Europe eye drops market are the rising prevalence of ophthalmic diseases and high incidence of age-related eye diseases.

What is the market CAGR value of America & Europe eye drops market during forecast period?

The CAGR value of the America & Europe eye drops market during the forecasted period of 2023-2031 is 5.3%.

Which drug class segment leads the America & Europe eye drops market?

Answer: - The antibiotics segment held the largest share of the market in the America & Europe eye drops market and held the largest market share of 37.64% in 2023.

Which application held the largest share in the America & Europe eye drops market?

The eye diseases segment dominated the America & Europe eye drops market and held the largest market share of 64.85% in 2023.

Who are the key players in the America & Europe eye drops market?

The America & Europe eye drops market majorly consists of the players such Alcon AG; AbbVie Inc; Bausch & Lomb Inc; Pfizer Inc; Prestige Consumer Healthcare Inc.; Similasan Corp; Rohto Pharmaceutical Co Ltd; Sager Pharma Kft; Akorn Operating Company LLC; Santen Pharmaceutical Co., Ltd.; SERVImed Industrial S.p.A.; and I-MED Pharma Inc.

What are eye drops?

Eye diseases can be treated with eye drops, which are more effective and less painful. Symptoms such as dry eye, redness, pain, itching, glaucoma, refractive error, conjunctivitis, diabetic macular edema, and age-related macular degeneration can be effectively treated using these products. Eye drops, also called artificial tears, are a class of therapeutics commonly used to simultaneously relieve the symptoms of dry and irritated eyes by moisturizing the eyes and protecting them from further infection.

Which are the top companies that hold the market share in America & Europe eye drops market?

Alcon AG and Bausch & Lomb Inc are the top two companies that hold huge market shares in the America & Europe eye drops market.

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. America and Europe Eye Drops Market Landscape

4.1 Overview

4.2 PEST Analysis

5. America and Europe Eye Drops Market – Key Market Dynamics

5.1 America and Europe Eye Drops Market – Key Market Dynamics

5.2 Market Drivers

5.2.1 Rising Prevalence of Ophthalmic Diseases

5.2.2 High Incidence of Age-Related Eye Diseases

5.3 Market Restraints

5.3.1 Rising Number of Product Recalls

5.4 Market Opportunities

5.4.1 Initiatives to Bolster Eye Care Awareness

5.5 Future Trends

5.5.1 Lifestyle Changes Affecting Eye Health

5.6 Impact:

6. America and Europe Eye Drops Market – Regional Market Analysis

6.1 America and Europe Eye Drops Market Revenue (US$ Million), 2023–2031

7. America and Europe Eye Drops Market Analysis – by Drug Class

7.1 Overview

7.2 Antibiotics

7.2.1 Overview

7.2.2 Antibiotics: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Artificial Tears

7.3.1 Overview

7.3.2 Artificial Tears: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)

7.4 Steroids

7.4.1 Overview

7.4.2 Steroids: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)

7.5 Others

7.5.1 Overview

7.5.2 Others: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)

8. America and Europe Eye Drops Market Analysis – by Application

8.1 Overview

8.2 Eye Diseases

8.2.1 Overview

8.2.2 Eye Diseases: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)

8.3 Eye Care

8.3.1 Overview

8.3.2 Eye Care: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)

8.4 Others

8.4.1 Overview

8.4.2 Others: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)

9. America and Europe Eye Drops Market Analysis – by Purchase Mode

9.1 Overview

9.2 Prescription

9.2.1 Overview

9.2.2 Prescription: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)

9.3 OTC

9.3.1 Overview

9.3.2 OTC: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)

10. America and Europe Eye Drops Market – Geographical Analysis

10.1 Overview

10.2 America

10.2.1 America Eye Drops Market Overview

10.2.2 America: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)

10.2.2.1 America: America and Europe Eye Drops Market – Revenue and Forecast Analysis – by Drug Class

10.2.2.1.1 America: America and Europe Eye Drops Market – Revenue and Forecast Analysis – by Antibiotics

10.2.2.1.2 America: America and Europe Eye Drops Market – Revenue and Forecast Analysis – by Artificial Tears

10.2.2.1.3 America: America and Europe Eye Drops Market – Revenue and Forecast Analysis – by Steroids

10.2.2.2 America: America and Europe Eye Drops Market – Revenue and Forecast Analysis – by Application

10.2.2.2.1 America: America and Europe Eye Drops Market – Revenue and Forecast Analysis – by Eye Diseases

10.2.2.3 America: America and Europe Eye Drops Market – Revenue and Forecast Analysis – by Purchase Mode

10.2.3 America: America and Europe Eye Drops Market – Revenue and Forecast Analysis – by Country

10.2.3.1 United States: Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)

10.2.3.1.1 Overview

10.2.3.1.2 United States: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)

10.2.3.1.3 United States: America and Europe Eye Drops Market Breakdown, by Drug Class

10.2.3.1.3.1 United States: America and Europe Eye Drops Market Breakdown, by Antibiotics

10.2.3.1.3.2 United States: America and Europe Eye Drops Market Breakdown, by Artificial Tears

10.2.3.1.3.3 United States: America and Europe Eye Drops Market Breakdown, by Steroids

10.2.3.1.4 United States: America and Europe Eye Drops Market Breakdown, by Application

10.2.3.1.4.1 United States: America and Europe Eye Drops Market Breakdown, by Eye Diseases

10.2.3.1.5 United States: America and Europe Eye Drops Market Breakdown, by Purchase Mode

10.2.3.2 Canada: Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)

10.2.3.2.1 Overview

10.2.3.2.2 Canada: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)

10.2.3.2.3 Canada: America and Europe Eye Drops Market Breakdown, by Drug Class

10.2.3.2.3.1 Canada: America and Europe Eye Drops Market Breakdown, by Antibiotics

10.2.3.2.3.2 Canada: America and Europe Eye Drops Market Breakdown, by Artificial Tears

10.2.3.2.3.3 Canada: America and Europe Eye Drops Market Breakdown, by Steroids

10.2.3.2.4 Canada: America and Europe Eye Drops Market Breakdown, by Application

10.2.3.2.4.1 Canada: America and Europe Eye Drops Market Breakdown, by Eye Diseases

10.2.3.2.5 Canada: America and Europe Eye Drops Market Breakdown, by Purchase Mode

10.2.3.3 Brazil: Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)

10.2.3.3.1 Overview

10.2.3.3.2 Brazil: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)

10.2.3.3.3 Brazil: America and Europe Eye Drops Market Breakdown, by Drug Class

10.2.3.3.3.1 Brazil: America and Europe Eye Drops Market Breakdown, by Antibiotics

10.2.3.3.3.2 Brazil: America and Europe Eye Drops Market Breakdown, by Artificial Tears

10.2.3.3.3.3 Brazil: America and Europe Eye Drops Market Breakdown, by Steroids

10.2.3.3.4 Brazil: America and Europe Eye Drops Market Breakdown, by Application

10.2.3.3.4.1 Brazil: America and Europe Eye Drops Market Breakdown, by Eye Diseases

10.2.3.3.5 Brazil: America and Europe Eye Drops Market Breakdown, by Purchase Mode

10.2.3.4 Mexico: Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)

10.2.3.4.1 Overview

10.2.3.4.2 Mexico: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)

10.2.3.4.3 Mexico: America and Europe Eye Drops Market Breakdown, by Drug Class

10.2.3.4.3.1 Mexico: America and Europe Eye Drops Market Breakdown, by Antibiotics

10.2.3.4.3.2 Mexico: America and Europe Eye Drops Market Breakdown, by Artificial Tears

10.2.3.4.3.3 Mexico: America and Europe Eye Drops Market Breakdown, by Steroids

10.2.3.4.4 Mexico: America and Europe Eye Drops Market Breakdown, by Application

10.2.3.4.4.1 Mexico: America and Europe Eye Drops Market Breakdown, by Eye Diseases

10.2.3.4.5 Mexico: America and Europe Eye Drops Market Breakdown, by Purchase Mode

10.2.3.5 Argentina: Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)

10.2.3.5.1 Overview

10.2.3.5.2 Argentina: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)

10.2.3.5.3 Argentina: America and Europe Eye Drops Market Breakdown, by Drug Class

10.2.3.5.3.1 Argentina: America and Europe Eye Drops Market Breakdown, by Antibiotics

10.2.3.5.3.2 Argentina: America and Europe Eye Drops Market Breakdown, by Artificial Tears

10.2.3.5.3.3 Argentina: America and Europe Eye Drops Market Breakdown, by Steroids

10.2.3.5.4 Argentina: America and Europe Eye Drops Market Breakdown, by Application

10.2.3.5.4.1 Argentina: America and Europe Eye Drops Market Breakdown, by Eye Diseases

10.2.3.5.5 Argentina: America and Europe Eye Drops Market Breakdown, by Purchase Mode

10.2.3.6 Chile: Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)

10.2.3.6.1 Overview

10.2.3.6.2 Chile: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)

10.2.3.6.3 Chile: America and Europe Eye Drops Market Breakdown, by Drug Class

10.2.3.6.3.1 Chile: America and Europe Eye Drops Market Breakdown, by Antibiotics

10.2.3.6.3.2 Chile: America and Europe Eye Drops Market Breakdown, by Artificial Tears

10.2.3.6.3.3 Chile: America and Europe Eye Drops Market Breakdown, by Steroids

10.2.3.6.4 Chile: America and Europe Eye Drops Market Breakdown, by Application

10.2.3.6.4.1 Chile: America and Europe Eye Drops Market Breakdown, by Eye Diseases

10.2.3.6.5 Chile: America and Europe Eye Drops Market Breakdown, by Purchase Mode

10.2.3.7 Rest of America: Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)

10.2.3.7.1 Overview

10.2.3.7.2 Rest of America: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)

10.2.3.7.3 Rest of America: America and Europe Eye Drops Market Breakdown, by Drug Class

10.2.3.7.3.1 Rest of America: America and Europe Eye Drops Market Breakdown, by Antibiotics

10.2.3.7.3.2 Rest of America: America and Europe Eye Drops Market Breakdown, by Artificial Tears

10.2.3.7.3.3 Rest of America: America and Europe Eye Drops Market Breakdown, by Steroids

10.2.3.7.4 Rest of America: America and Europe Eye Drops Market Breakdown, by Application

10.2.3.7.4.1 Rest of America: America and Europe Eye Drops Market Breakdown, by Eye Diseases

10.2.3.7.5 Rest of America: America and Europe Eye Drops Market Breakdown, by Purchase Mode

10.3 Europe

10.3.1 Overview

10.3.2 Europe: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)

10.3.2.1 Europe: America and Europe Eye Drops Market – Revenue and Forecast Analysis – by Drug Class

10.3.2.1.1 Europe: America and Europe Eye Drops Market – Revenue and Forecast Analysis – by Antibiotics

10.3.2.1.2 Europe: America and Europe Eye Drops Market – Revenue and Forecast Analysis – by Artificial Tears

10.3.2.1.3 Europe: America and Europe Eye Drops Market – Revenue and Forecast Analysis – by Steroids

10.3.2.2 Europe: America and Europe Eye Drops Market – Revenue and Forecast Analysis – by Application

10.3.2.2.1 Europe: America and Europe Eye Drops Market – Revenue and Forecast Analysis – by Eye Diseases

10.3.2.3 Europe: America and Europe Eye Drops Market – Revenue and Forecast Analysis – by Purchase Mode

10.3.3 Europe: America and Europe Eye Drops Market – Revenue and Forecast Analysis – by Country

10.3.3.1 Germany: Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)

10.3.3.1.1 Overview

10.3.3.1.2 Germany: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)

10.3.3.1.3 Germany: America and Europe Eye Drops Market Breakdown, by Drug Class

10.3.3.1.3.1 Germany: America and Europe Eye Drops Market Breakdown, by Antibiotics

10.3.3.1.3.2 Germany: America and Europe Eye Drops Market Breakdown, by Artificial Tears

10.3.3.1.3.3 Germany: America and Europe Eye Drops Market Breakdown, by Steroids

10.3.3.1.4 Germany: America and Europe Eye Drops Market Breakdown, by Application

10.3.3.1.4.1 Germany: America and Europe Eye Drops Market Breakdown, by Eye Diseases

10.3.3.1.5 Germany: America and Europe Eye Drops Market Breakdown, by Purchase Mode

10.3.3.2 France: Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)

10.3.3.2.1 Overview

10.3.3.2.2 France: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)

10.3.3.2.3 France: America and Europe Eye Drops Market Breakdown, by Drug Class

10.3.3.2.3.1 France: America and Europe Eye Drops Market Breakdown, by Antibiotics

10.3.3.2.3.2 France: America and Europe Eye Drops Market Breakdown, by Artificial Tears

10.3.3.2.3.3 France: America and Europe Eye Drops Market Breakdown, by Steroids

10.3.3.2.4 France: America and Europe Eye Drops Market Breakdown, by Application

10.3.3.2.4.1 France: America and Europe Eye Drops Market Breakdown, by Eye Diseases

10.3.3.2.5 France: America and Europe Eye Drops Market Breakdown, by Purchase Mode

10.3.3.3 United Kingdom: Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)

10.3.3.3.1 Overview

10.3.3.3.2 United Kingdom: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)

10.3.3.3.3 United Kingdom: America and Europe Eye Drops Market Breakdown, by Drug Class

10.3.3.3.3.1 United Kingdom: America and Europe Eye Drops Market Breakdown, by Antibiotics

10.3.3.3.3.2 United Kingdom: America and Europe Eye Drops Market Breakdown, by Artificial Tears

10.3.3.3.3.3 United Kingdom: America and Europe Eye Drops Market Breakdown, by Steroids

10.3.3.3.4 United Kingdom: America and Europe Eye Drops Market Breakdown, by Application

10.3.3.3.4.1 United Kingdom: America and Europe Eye Drops Market Breakdown, by Eye Diseases

10.3.3.3.5 United Kingdom: America and Europe Eye Drops Market Breakdown, by Purchase Mode

10.3.3.4 Italy: Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)

10.3.3.4.1 Overview

10.3.3.4.2 Italy: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)

10.3.3.4.3 Italy: America and Europe Eye Drops Market Breakdown, by Drug Class

10.3.3.4.3.1 Italy: America and Europe Eye Drops Market Breakdown, by Antibiotics

10.3.3.4.3.2 Italy: America and Europe Eye Drops Market Breakdown, by Artificial Tears

10.3.3.4.3.3 Italy: America and Europe Eye Drops Market Breakdown, by Steroids

10.3.3.4.4 Italy: America and Europe Eye Drops Market Breakdown, by Application

10.3.3.4.4.1 Italy: America and Europe Eye Drops Market Breakdown, by Eye Diseases

10.3.3.4.5 Italy: America and Europe Eye Drops Market Breakdown, by Purchase Mode

10.3.3.5 Spain: Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)

10.3.3.5.1 Overview

10.3.3.5.2 Spain: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)

10.3.3.5.3 Spain: America and Europe Eye Drops Market Breakdown, by Drug Class

10.3.3.5.3.1 Spain: America and Europe Eye Drops Market Breakdown, by Antibiotics

10.3.3.5.3.2 Spain: America and Europe Eye Drops Market Breakdown, by Artificial Tears

10.3.3.5.3.3 Spain: America and Europe Eye Drops Market Breakdown, by Steroids

10.3.3.5.4 Spain: America and Europe Eye Drops Market Breakdown, by Application

10.3.3.5.4.1 Spain: America and Europe Eye Drops Market Breakdown, by Eye Diseases

10.3.3.5.5 Spain: America and Europe Eye Drops Market Breakdown, by Purchase Mode

10.3.3.6 Rest of Europe: Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)

10.3.3.6.1 Overview

10.3.3.6.2 Rest of Europe: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)

10.3.3.6.3 Rest of Europe: America and Europe Eye Drops Market Breakdown, by Drug Class

10.3.3.6.3.1 Rest of Europe: America and Europe Eye Drops Market Breakdown, by Antibiotics

10.3.3.6.3.2 Rest of Europe: America and Europe Eye Drops Market Breakdown, by Artificial Tears

10.3.3.6.3.3 Rest of Europe: America and Europe Eye Drops Market Breakdown, by Steroids

10.3.3.6.4 Rest of Europe: America and Europe Eye Drops Market Breakdown, by Application

10.3.3.6.4.1 Rest of Europe: America and Europe Eye Drops Market Breakdown, by Eye Diseases

10.3.3.6.5 Rest of Europe: America and Europe Eye Drops Market Breakdown, by Purchase Mode

11. Industry Landscape

11.1 Overview

11.2 Growth Strategies in the America and Europe Eye Drops Market

11.3 Organic Growth Strategies

11.3.1 Overview

11.4 Inorganic Growth Strategies

11.4.1 Overview

12. Company Profiles

12.1 Alcon AG

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 AbbVie Inc

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Bausch & Lomb Inc

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Pfizer Inc

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Prestige Consumer Healthcare Inc.

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Similasan Corp

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Rohto Pharmaceutical Co Ltd

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 Sager Pharma Kft

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 Akorn Operating Company LLC

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 Santen Pharmaceutical Co., Ltd.

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Products and Services

12.10.4 Financial Overview

12.10.5 SWOT Analysis

12.10.6 Key Developments

12.11 SERVImed Industrial S.p.A.

12.11.1 Key Facts

12.11.2 Business Description

12.11.3 Products and Services

12.11.4 Financial Overview

12.11.5 SWOT Analysis

12.11.6 Key Developments

12.12 I-MED Pharma Inc.

12.12.1 Key Facts

12.12.2 Business Description

12.12.3 Products and Services

12.12.4 Financial Overview

12.12.5 SWOT Analysis

12.12.6 Key Developments

13. Appendix

13.1 About The Insight Partners

List of Tables

Table 1. America and Europe Eye Drops Market Segmentation

Table 2. America: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class

Table 3. America: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Antibiotics

Table 4. America: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Artificial Tears

Table 5. America: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Steroids

Table 6. America: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 7. America: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Eye Diseases

Table 8. America: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Purchase Mode

Table 9. United States: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class

Table 10. United States: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Antibiotics

Table 11. United States: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Artificial Tears

Table 12. United States: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Steroids

Table 13. United States: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 14. United States: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Eye Diseases

Table 15. United States: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Purchase Mode

Table 16. Canada: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class

Table 17. Canada: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Antibiotics

Table 18. Canada: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Artificial Tears

Table 19. Canada: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Steroids

Table 20. Canada: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 21. Canada: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Eye Diseases

Table 22. Canada: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Purchase Mode

Table 23. Brazil: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class

Table 24. Brazil: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Antibiotics

Table 25. Brazil: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Artificial Tears

Table 26. Brazil: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Steroids

Table 27. Brazil: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 28. Brazil: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Eye Diseases

Table 29. Brazil: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Purchase Mode

Table 30. Mexico: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class

Table 31. Mexico: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Antibiotics

Table 32. Mexico: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Artificial Tears

Table 33. Mexico: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Steroids

Table 34. Mexico: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 35. Mexico: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Eye Diseases

Table 36. Mexico: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Purchase Mode

Table 37. Argentina: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class

Table 38. Argentina: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Antibiotics

Table 39. Argentina: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Artificial Tears

Table 40. Argentina: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Steroids

Table 41. Argentina: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 42. Argentina: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Eye Diseases

Table 43. Argentina: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Purchase Mode

Table 44. Chile: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class

Table 45. Chile: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Antibiotics

Table 46. Chile: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Artificial Tears

Table 47. Chile: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Steroids

Table 48. Chile: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 49. Chile: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Eye Diseases

Table 50. Chile: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Purchase Mode

Table 51. Rest of America: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class

Table 52. Rest of America: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Antibiotics

Table 53. Rest of America: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Artificial Tears

Table 54. Rest of America: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Steroids

Table 55. Rest of America: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 56. Rest of America: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Eye Diseases

Table 57. Rest of America: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Purchase Mode

Table 58. Europe: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class

Table 59. Europe: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Antibiotics

Table 60. Europe: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Artificial Tears

Table 61. Europe: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Steroids

Table 62. Europe: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 63. Europe: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Eye Diseases

Table 64. Europe: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Purchase Mode

Table 65. Germany: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class

Table 66. Germany: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Antibiotics

Table 67. Germany: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Artificial Tears

Table 68. Germany: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Steroids

Table 69. Germany: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 70. Germany: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Eye Diseases

Table 71. Germany: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Purchase Mode

Table 72. France: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class

Table 73. France: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Antibiotics

Table 74. France: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Artificial Tears

Table 75. France: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Steroids

Table 76. France: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 77. France: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Eye Diseases

Table 78. France: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Purchase Mode

Table 79. United Kingdom: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class

Table 80. United Kingdom: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Antibiotics

Table 81. United Kingdom: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Artificial Tears

Table 82. United Kingdom: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Steroids

Table 83. United Kingdom: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 84. United Kingdom: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Eye Diseases

Table 85. United Kingdom: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Purchase Mode

Table 86. Italy: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class

Table 87. Italy: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Antibiotics

Table 88. Italy: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Artificial Tears

Table 89. Italy: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Steroids

Table 90. Italy: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 91. Italy: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Eye Diseases

Table 92. Italy: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Purchase Mode

Table 93. Spain: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class

Table 94. Spain: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Antibiotics

Table 95. Spain: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Artificial Tears

Table 96. Spain: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Steroids

Table 97. Spain: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 98. Spain: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Eye Diseases

Table 99. Spain: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Purchase Mode

Table 100. Rest of Europe: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class

Table 101. Rest of Europe: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Antibiotics

Table 102. Rest of Europe: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Artificial Tears

Table 103. Rest of Europe: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Steroids

Table 104. Rest of Europe: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 105. Rest of Europe: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Eye Diseases

Table 106. Rest of Europe: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Purchase Mode

Table 107. Recent Organic Growth Strategies in the America and Europe Eye Drops Market

Table 108. Recent Inorganic Growth Strategies in the America and Europe Eye Drops Market

List of Figures

Figure 1. America and Europe Eye Drops Market Segmentation, by Geography

Figure 2. PEST Analysis

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. America and Europe Eye Drops Market Revenue (US$ Million), 2023–2031

Figure 5. Eye Drops Market Breakdown by Geography, 2023 and 2031 (%)

Figure 6. America and Europe Eye Drops Market Share (%) – by Drug Class (2023 and 2031)

Figure 7. Antibiotics: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)

Figure 8. Artificial Tears: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)

Figure 9. Steroids: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)

Figure 10. Others: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)

Figure 11. America and Europe Eye Drops Market Share (%) – by Application (2023 and 2031)

Figure 12. Eye Diseases: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)

Figure 13. Eye Care: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)

Figure 14. Others: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)

Figure 15. America and Europe Eye Drops Market Share (%) – by Purchase Mode (2023 and 2031)

Figure 16. Prescription: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)

Figure 17. OTC: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)

Figure 18. America and Europe Eye Drops Market Breakdown by Region, 2023 and 2031 (%)

Figure 19. America: Eye Drops Market, by Key Country – Revenue (2023) (US$ Million)

Figure 20. America: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million)

Figure 21. America: America and Europe Eye Drops Market Breakdown, by Key Countries, 2023 and 2031 (%)

Figure 22. United States: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million)

Figure 23. Canada: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million)

Figure 24. Brazil: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million)

Figure 25. Mexico: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million)

Figure 26. Argentina: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million)

Figure 27. Chile: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million)

Figure 28. Rest of America: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million)

Figure 29. Europe: Eye Drops Market, by Key Country – Revenue (2023) (US$ Million)

Figure 30. Europe: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million)

Figure 31. Europe: America and Europe Eye Drops Market Breakdown, by Key Countries, 2023 and 2031 (%)

Figure 32. Germany: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million)

Figure 33. France: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million)

Figure 34. United Kingdom: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million)

Figure 35. Italy: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million)

Figure 36. Spain: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million)

Figure 37. Rest of Europe: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million)

Figure 38. Growth Strategies in the America and Europe Eye Drops Market

Your Key Concerns Addressed - Question & Answer
Can I view a sample of the report before purchasing?

Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

Is analyst support included with the purchase?

Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

What are the next steps once I place an order?

Once your order is successfully placed, you will receive a confirmation email along with your invoice.

• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

Can the report be tailored to suit my specific needs?

We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.

In what format is the report delivered?

The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

How secure is the payment process on your platform?

Our payment process is fully secure and PCI-DSS compliant.

We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.

Do you provide special pricing for buying multiple reports?

Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.

Can I connect with your team to discuss the report before buying?

Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

Will I get a billing invoice upon purchase?

Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.

Is there support available if I can't access my report?

Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Please use your business email for quicker response
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.